A large group of patients with suspected allergic reactions to beta-la
ctam antibiotics was evaluated. A detailed clinical history, together
with skin tests, RAST (radioallergosorbent test), and controlled chall
enge tests, was used to establish whether patients allergic to beta-la
ctam antibiotics had selective immediate allergic responses to amoxici
llin (AX) or were cross-reacting with other penicillin derivatives. Sk
in tests were performed with benzylpenicilloyl-poly-L-lysine (BPO-PLL)
, benzylpenicilloate, benzylpenicillin (PG), ampicillin (AMP), and AX.
RAST for BPO-PLL and AX-PLL was done. When both skin test and RAST fo
r BPO were negative, single-blind, placebo-controlled challenge tests
were done to ensure tolerance of PG or sensitivity to AX. A total of 1
77 patients were diagnosed as allergic to beta-lactam antibiotics. We
selected the 54 (30.5%) cases of immediate AX allergy with good tolera
nce of PG. Anaphylaxis was seen in 37 patients (69%), the other 17 (31
%) having urticaria and/or angioedema. All the patients were skin test
negative to BPO; 49 of 51 (96%) were also negative to MDM, and 44 of
46 (96%) to PG. Skin tests with AX were positive in 34 (63%) patients.
RAST was positive for AX in 22 patients (41%) and to BPO in just 5 (9
0%). None of the sera with negative RAST for AX were positive to BPO.
Challenge tests with AX were performed in 23 subjects (43%) to establi
sh the diagnosis of immediate allergic reaction to AX, and in 15 cases
(28%) both skin test and RAST for AX were negative. PG was well toler
ated by all 54 patients. We describe the largest group of AX-allergic
patients who have tolerated PG reported so far. Diagnosis of these pat
ients can be achieved only if specific AX-related reagents are employe
d. Further studies are necessary to determine the exact extent of this
problem and to improve the efficacy of diagnostic methods.